Conference Coverage
Conference Coverage
New risk-prediction model for diabetes under development
LOS ANGELES – Efforts are under way to apply it in clinical practice settings.
Conference Coverage
Rheumatologist prescribing rates predict chronic opioid use in RA patients
CHICAGO – Higher baseline opioid prescribing rates among physicians predict chronic opioid use in RA patients.
Conference Coverage
Extended Holter screening finds A-fib faster after ischemic strokes
MONTREAL – Extended screening of acute ischemic stroke patients for A-fib finds arrhythmias faster than standard work-ups.
Conference Coverage
New PTSD prevention guidelines released
BARCELONA – “We’re really struggling from a pharmacologic perspective to know what to do,” said Dr. Jonathan I. Bisson, chair of the ISTSS...
Conference Coverage
Phase 3 data support apixaban for cancer-associated VTE
The rate of major bleeding was similar with apixaban and dalteparin.
Conference Coverage
Rural teleprescribing for opioid use disorder shows success
BONITA SPRINGS, FLA. – More than 56% of rural counties in the country have no buprenorphine provider.
Conference Coverage
NCI director: Data failures cost lives
SAN DIEGO – Too many patients die because numbers aren’t aggregated or shared, Dr. Ned Sharpless said at the ASH meeting.
Conference Coverage
Study elicits patients’ most disturbing epilepsy symptoms
NEW ORLEANS – The most prominent symptoms and functional impacts of epilepsy may differ in the early, middle, and late stages of the disease.
Conference Coverage
Study investigates statin-diabetes link
Complete results are expected by the end of 2019.
Conference Coverage
Should metabolic syndrome be renamed circadian syndrome?
Cluster of conditions “is now the main driver of the global chronic disease epidemic and its health burden,” expert says.